Research protocols using 5-Amino-1MQ typically administer 50100mg daily via subcutaneous injection, based on human equivalent dose scaling from rodent studies where 10mg/kg bodyweight produced measurable NNMT suppression and increased NAD+ bioavailability
The compounds quinolinium scaffold mimics nicotinamides structure, allowing it to compete for the NNMT active site while avoiding interactions with other enzymes
The fat cell targeting mechanism remains active, but with less total adipose tissue available to mobilize, changes occur more gradually
The combination of peptides with other therapies, such as gene therapy or immunotherapy, holds the potential for more effective treatments for complex diseases
Experience an immediate increase in energy levels to help you overcome fatigue, enhanced metabolism which can aid in weight management, improved mood regulation contributing to better mental health, and support for your nervous system and blood cells